Pharmacogenetics and Genomics, 1744-6872

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation

    Nenonen, H. A., Lindgren, I. A., Prahl, A. S., Trzybulska, D., Isabella Kharraziha, Hultén, M., Yvonne L Giwercman & Henic, E., 2019, I : Pharmacogenetics and Genomics. 29, 5, s. 114–120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2012
  4. Pregnancy and the methyltransferase genotype independently influence the arsenic methylation phenotype.

    Gardner, R. M., Karin Engström, Bottai, M., Hoque, W. A. M., Raqib, R., Karin Broberg Palmgren & Vahter, M., 2012, I : Pharmacogenetics & Genomics. 22, 7, s. 508-516

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2011
  6. Estrogen receptor alpha single nucleotide polymorphism modifies the risk of azoospermia in childhood cancer survivors

    Patrik Romerius, Aleksander Giwercman, Christian Moëll, Relander, T., Cavallin-Ståhl, E., Thomas Wiebe, Halldén, C. & Yvonne Giwercman, 2011, I : Pharmacogenetics & Genomics. 21, 5, s. 263-269

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2010
  8. Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene

    Appell, M. L., Wennerstrand, P., Peterson, C., Erik Hertervig & Martensson, L-G., 2010, I : Pharmacogenetics & Genomics. 20, 11, s. 700-707

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.

    Cristiano Fava, Montagnana, M., Danese, E., Almgren, P., Bo Hedblad, Gunnar Engström, Berglund, G., Minuz, P. & Olle Melander, 2010, I : Pharmacogenetics & Genomics. 20, 2, s. 94-103

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate.

    Karin Broberg Palmgren, Warholm, M., Håkan Tinnerberg, Anna Axmon, Jönsson, B. A., Sennbro, C. J., Margareta Littorin & Rannug, A., 2010, I : Pharmacogenetics & Genomics. 20, 2, s. 104-111

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2007
  12. Androgen receptor gene CAG repeat length as a modifier of the association between persistent organohalogen pollutant exposure markers and semen characteristics

    Aleksander Giwercman, Lars Rylander, Anna Rignell-Hydbom, Jönsson, B. A., Pedersen, H. S., Ludwicki, J. K., Lesovoy, V., Zvyezday, V., Spano, M., Manicardi, G-C., Bizzaro, D., Bonefeld-Jorgensen, E. C., Toft, G., Bonde, J. P., Giwercman, C., Tiido, T. & Yvonne Giwercman, 2007, I : Pharmacogenetics & Genomics. 17, 6, s. 391-401

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2006
  14. Remarkably low incidence of hypospadias in Greenland despite high exposure to endocrine disrupters; possible protective effect of androgen receptor genotype.

    Yvonne Giwercman, Erik Kleist, K., Aleksander Giwercman, Giwercman, C., Toft, G., Bonde, J-P. & Pedersen, H., 2006, I : Pharmacogenetics & Genomics. 16, 5, s. 375-377

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift